Stockreport

Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications

Amyris, Inc.  (AMRS) 
Last amyris, inc. earnings: 3/12 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amyris.com/investor-relations
PDF Sustainable Squalene Replacement Needed for Pharma EMERYVILLE, Calif. and SEATTLE, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), and IDRI (Infectious [Read more]